Back to IGCView Full Landscape
Phase 2
Development Phase
1
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
Upcoming Catalysts
What are catalysts?Competitive Landscape
10 competitors in Alzheimer Disease
SAVASimufilam
Phase 3SNYxaliproden (SR57746A)
Phase 3BIIBBIIB080
Phase 2SNYAVE1625
Phase 2NRSNPrimeC
Phase 2Drug Information
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts